Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Lucore

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Catheterization and Cardiovascular Diagnosis|January 1, 1997
One balloon, one stent: an effective cost-containment strategy for elective stent deploymentK J Rocha-Singh, R V Trask, C L Lucore, et al.
Thrombosis and Haemostasis|November 30, 1990
Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cellsS Fujii, C L Lucore, W E Hopkins, et al.
The Journal of Biological Chemistry|November 5, 1988
Regulation of the expression of type 1 plasminogen activator inhibitor in Hep G2 cells by epidermal growth factorC L Lucore, S Fujii, T C Wun, et al.
The American Journal of Cardiology|June 15, 1989
Potential attenuation of fibrinolysis by growth factors released from platelets and their pharmacologic implicationsS Fujii, C L Lucore, W E Hopkins, et al.
The Journal of Biological Chemistry|June 25, 1989
Characterization of interaction of active-site serine mutants of tissue-type plasminogen activator with plasminogen activator inhibitor-1J C Monge, C L Lucore, E T Fry, et al.
Diabetes|January 1, 1994
Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patientsJ B McGill, D J Schneider, C L Arfken, et al.
Journal of the American College of Cardiology|December 10, 1999
Clopidogrel as adjunctive antiplatelet therapy during coronary stentingG J Mishkel, F V Aguirre, R W Ligon, et al.
Archives of Internal Medicine|March 20, 2001
New approaches to diagnosis and management of unstable angina and non-ST-segment elevation myocardial infarctionR A O'Rourke, J S Hochman, M C Cohen, et al.
Coronary Artery Disease|April 3, 2001
Impact of abciximab and coronary stenting on outcomes and costs of percutaneous coronary interventions in a community hospitalC L Lucore, R V Trask, G J Mishkel, et al.
Radiology|April 1, 1995
Nephrotoxicity from contrast media: attenuation with theophyllineR E Katholi, G J Taylor, W P McCann, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Catheterization and Cardiovascular Diagnosis|January 1, 1997
One balloon, one stent: an effective cost-containment strategy for elective stent deploymentK J Rocha-Singh, R V Trask, C L Lucore, et al.
Thrombosis and Haemostasis|November 30, 1990
Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cellsS Fujii, C L Lucore, W E Hopkins, et al.
The Journal of Biological Chemistry|November 5, 1988
Regulation of the expression of type 1 plasminogen activator inhibitor in Hep G2 cells by epidermal growth factorC L Lucore, S Fujii, T C Wun, et al.
The American Journal of Cardiology|June 15, 1989
Potential attenuation of fibrinolysis by growth factors released from platelets and their pharmacologic implicationsS Fujii, C L Lucore, W E Hopkins, et al.
The Journal of Biological Chemistry|June 25, 1989
Characterization of interaction of active-site serine mutants of tissue-type plasminogen activator with plasminogen activator inhibitor-1J C Monge, C L Lucore, E T Fry, et al.
Diabetes|January 1, 1994
Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patientsJ B McGill, D J Schneider, C L Arfken, et al.
Journal of the American College of Cardiology|December 10, 1999
Clopidogrel as adjunctive antiplatelet therapy during coronary stentingG J Mishkel, F V Aguirre, R W Ligon, et al.
Archives of Internal Medicine|March 20, 2001
New approaches to diagnosis and management of unstable angina and non-ST-segment elevation myocardial infarctionR A O'Rourke, J S Hochman, M C Cohen, et al.
Coronary Artery Disease|April 3, 2001
Impact of abciximab and coronary stenting on outcomes and costs of percutaneous coronary interventions in a community hospitalC L Lucore, R V Trask, G J Mishkel, et al.
Radiology|April 1, 1995
Nephrotoxicity from contrast media: attenuation with theophyllineR E Katholi, G J Taylor, W P McCann, et al.
Pageof 2